Boston Scientific Launches Precision Spectra™ Spinal Cord Stimulator System in US

Boston Scientific Corporation (NYSE: BSX ) has received approval by the U.S. Food and Drug Administration and is beginning a limited launch of the Precision Spectra Spinal Cord Stimulator (SCS) System. The Precision Spectra System is the world's first and only SCS system with Illumina 3D™ software and 32 contacts, and is designed